Skip to main content

Stimulation of soluble guanylate cyclase accelerates renal recovery following relief of unilateral ureteral obstruction

Background

Unilateral ureteral obstruction (UUO) is characterized by progressive renal atrophy, tubular apoptosis and tubulointerstitial fibrosis. Pharmacological stimulation of soluble guanylate cyclase (sGC) and subsequent cGMP production have recently been found to be renoprotective. In this study, the sGC stimulator BAY 41-8543 was given to rats after relief of UUO in order to analyze the effects of enhanced NO/sGC/cGMP signaling on the subsequent renal disease recovery, concerning the renal atrophy, tubular apoptosis and tubulointerstitial fibrosis.

Methods

Male Sprague-Dawley rats underwent UUO. After 5 days, the obstruction was relieved and the rats were randomly assigned to UUO-Relief and UUO-Relief plus BAY 41-8543 (10 mg/kg body weight/day). After 7 days of treatment, effects of stimulated sGC/cGMP on plasma cGMP levels, systolic blood pressure and renal histology were determined. The symbol * indicates p < 0.05 UUO-Relief versus UUO-Relief plus BAY 41-8543.

Results

Untreated UUO-Relief rats showed elevation of systolic blood pressure, marked tubular atrophy, tubular apoptosis, tubulointerstitial macrophage infiltration and fibrosis. Compared to the untreated rats with UUO-Relief, BAY 41-8543 treatment increased significantly plasma cGMP levels (+104%*). This went along with significant reductions in systolic blood pressure (UUO-Relief plus BAY 41-8543 vs UUO-Relief: 112 ± 4 vs 145 ± 8 mmHg*), tubular diameter (-20%*), tubular apoptosis (-67%*) shown in TUNEL assay, tubulointerstitial macrophage infiltration (-65%*) and fibrosis (tubulointerstitial volume -38%*, expansion of matrix proteins -60%*, deposition of collagen IV -52%* and expression of alpha-smooth muscle actin -69%*).

Conclusion

Stimulation of sGC by Bay 41-8543 significantly increased cGMP production and precedes the disease resolution following relief of UUO. This involved improvements in renal atrophy, tubular apoptosis, tubulointerstitial fibrosis and macrophage infiltration. The findings suggest that pharmacological sGC stimulation is an effective approach to accelerate restoration of renal architecture and function following relief of ureteral obstruction.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yingrui Wang-Rosenke.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Wang-Rosenke, Y., Khadzhynov, D., Loof, T. et al. Stimulation of soluble guanylate cyclase accelerates renal recovery following relief of unilateral ureteral obstruction. BMC Pharmacol 9, P71 (2009). https://doi.org/10.1186/1471-2210-9-S1-P71

Download citation

Keywords

  • Systolic Blood Pressure
  • Unilateral Ureteral Obstruction
  • Ureteral Obstruction
  • Soluble Guanylate Cyclase
  • Tubulointerstitial Fibrosis